Media Partners

2026 Media Partners

Take a look at the media partners who decided to support the 8th CKD Drug Development Summit. If you are interested in a media partnership, please contact info@hansonwade.com.

ProKidney Corp

Learn more:

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cell therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, rilparencel (also known as REACT®), is a first-in-class, patented, proprietary autologous cell therapy with regenerative medicine advanced therapy designation that is being evaluated in the ongoing Phase 3 REGEN-006 (PROACT 1) study for its potential to preserve kidney function in patients with advanced CKD and type 2 diabetes. For more information, please visit www.prokidney.com.

News-Medical

Learn more:

For twenty years, News-Medical has been a trusted resource for life science scientists and healthcare professionals. As a proud member of the AZoNetwork family, we provide a free, expertly curated hub featuring the latest innovations in healthcare, research, and technology. Based in the UK and Australia, our reach is truly global, with over 38 million annual users. www.news-medical.net